Connect with us

Technology

Digital Twins in Healthcare Market worth $101.19 billion by 2031 | MarketsandMarkets™

Published

on

DELRAY BEACH, Fla., April 22, 2026 /PRNewswire/ — According to MarketsandMarkets™, the Digital Twins in Healthcare Market is projected to grow from about USD 7.47 billion in 2026 to USD 101.19 billion by 2031, at a CAGR of 68.4%.

Browse through 110 market data tables and 40 figures spread across 180 pages and the in-depth TOC on the “Digital Twins in Healthcare Market – Global Forecast to 2031”

Digital Twins in Healthcare Market Size & Forecast:

Market Size Available for Years: 2025–20312026 Market Size: USD 7.47 billion2031 Projected Market Size: USD 101.19 billionCAGR (2026–2031): 68.4%

Digital Twins in Healthcare Market Trends & Insights:

By type, the body part twins segment is projected to register the fastest growth of 69.0% in the global digital twins in healthcare market.In 2025, by component, the software segment accounted for the largest share of 58.1% of the digital twins in healthcare market.By region, North America accounted for the largest share of 48.2% of the global digital twins in healthcare market in 2025.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=74014375

The market is growing at a remarkable pace, mainly due to increased investments, technological innovations, and rising acceptance in clinical research and healthcare provision. Digital twins represent simulated models of patients, organs, and other aspects of the healthcare system as technologies advance into predictive and data-driven healthcare delivery. Thousands of clinical studies currently registered on ClinicalTrials.gov show that there is an emerging interest in developing advanced techniques involving the use of virtual simulations and modeling for efficient trial processes. Moreover, the rise in investment activities further promotes innovation within the industry. For instance, Twin Health (US), which utilizes digital twin technology to create personalized metabolic health products, made headlines when it raised another USD 50 million after its earlier USD 140 million Series C fundraising. The firm seeks to develop and scale up its digital twin platform, which combines AI technology and simulation in providing healthcare services. Moreover, regulatory agencies, including the FDA in the United States, are encouraging computational modeling and simulations in order to increase or decrease the number of traditional clinical trials conducted. With healthcare organizations relying more and more on real-time data collected through wearables, imaging technology and electronic health records, digital twins are contributing towards better predictions of illness progression and therapeutic effects.

By type, the body part twins segment is expected to register the fastest growth in the digital twins in healthcare market during the forecast period.

the market for digital twins in healthcare has been divided into process twins, system twins, whole body twins, and body part twins, with the body part twins segment expected to witness the highest growth rate in the forecast period. Such a tendency can be explained by an increasing number of cases when digital models for certain organs are applied in clinical practice. Unlike whole-body digital models, organ models are much simpler and thus easier to implement in medical practice and to validate. They can be used for personalized medicine applications to help plan treatment, simulate surgery and assess how diseases progress. Moreover, recent developments prove that such a trend is likely to become even stronger. Namely, there has been an example when digital twin models of certain organs, such as the esophagus and heart, have been used in hospitals to simulate the results of surgical intervention. In addition, a wider application of AI, IoT, and real-time data in medicine means that the development of organ models becomes faster and more efficient than the development of whole-body models.

Request Sample Pages@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=74014375

By end user, the healthcare providers segment accounted for the largest share of the digital twins in healthcare market.

the digital twins in healthcare market is segmented into pharma & biopharma companies, research & academia, healthcare providers, medical device companies, and other end users (payers, diagnostic labs, patients, and CROs). Healthcare providers accounted for the largest share of the digital twins in healthcare market in 2025. This high growth is attributed to the improved diagnostic ability in hospitals, increased adoption of telemedicine & telehealth in the healthcare industry and increasing digital twin adoption in the healthcare industry. Also, digital twins will help to plan and design hospitals by modeling different floor plans, layout plans, and workflows.

North America registered the largest share in the global digital twins in healthcare market in 2025.

The region’s leadership in this area is mainly characterized by the prevalence of the adoption of advanced digital technologies, well-developed infrastructure for healthcare information technology, and active involvement in clinical research. The leading country here is the US due to increased adoption of AI technologies, real-world data, and simulation in both clinical practice and research. Besides, the contribution to the spread of digital twins has been made by the US Food and Drug Administration, which promotes the use of modeling and simulation technologies in drug development. Another reason why the US occupies the leading position in terms of adoption of digital twin technologies is that there are many reputable healthcare organizations and clinics, such as Mayo Clinic and Massachusetts General Hospital, conducting clinical studies focused on the application of AI and data analysis for personalized medicine. Finally, digital twin solutions have become more advanced thanks to technology developers such as Microsoft Corporation and GE HealthCare, who develop digital twin technology based on cloud technology and advanced imaging systems.

Inquire Before Buying@ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=74014375

Top Companies in Digital Twins in Healthcare Market:

The Top Companies in Digital Twins in Healthcare Market include Microsoft Corporation (US), Siemens Healthineers AG (Germany), Koninklijke Philips N.V. (Netherlands), Amazon Web Services, Inc. (US), Dassault Systèmes (France), GE Healthcare (US), IBM (US), NVIDIA Corporation (US), Oracle Corporation (US), PTC (US), SAP (Germany), Atos SE (France), ANSYS, Inc. (US), Faststream Technologies (US), Rescale, Inc. (US), Twin Health (US), NUREA (France), Predictiv (US), Verto (Canada), Qbio (US), Virtonomy GmbH (Germany), Unlearn.ai, Inc. (US), ThoughtWire (Canada), Sim and Cure (France), and PrediSurge (France).

Browse Adjacent Markets: Healthcare IT Market Research Reports & Consulting

Related Reports:

Drug Discovery Services Market – Global Forecast to 2030

Healthcare IT Market – Global Forecast to 2030

Healthcare Education Market – Global Forecast to 2028        

Healthcare Analytics Market – Global Forecast to 2030

IoT Medical Devices Market – Global Forecast to 2030

About MarketsandMarkets™ 

MarketsandMarkets™ has been recognized as one of America’s Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ‘GIVE Growth’ principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

MarketsandMarkets™ SalesPlay is an AI-driven Revenue Intelligence Co-Pilot designed to help revenue teams prioritize the right accounts, identify critical changes early, and surface opportunities ahead of demand, so pipeline builds naturally and deals close with greater consistency.

To find out more, visit www.MarketsandMarkets™.com or follow us on TwitterLinkedIn and Facebook.

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/

Logo: https://mma.prnewswire.com/media/1868219/5909825/MarketsandMarkets_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/digital-twins-in-healthcare-market-worth-101-19-billion-by-2031–marketsandmarkets-302750019.html

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Hexagon Interim Report 1 January – 31 March 2026

Published

on

By

STOCKHOLM, April 23, 2026 /PRNewswire/ —

First quarter 2026

Continuing operations

Operating net sales of 963.8 (961.5) resulting in organic growth of 8%Net sales including acquired deferred revenue amounted to 963.6 MEUR (961.5)Adjusted gross earnings of 606.3 (619.1) resulting in a 62.9% (64.4) gross marginAdjusted operating earnings (EBIT1) of 251.3 MEUR (248.7) resulting in a 26.1% (25.9) EBIT1 marginAdjusted earnings per share of 6.7 Euro cent (6.5)Earnings per share of 58.4 Euro cent (5.0)Cash conversion of 77% (60)Recurring revenue of 289.9 MEUR (308.0), 6% organic growthOctave reported operating net sales of 327.2 MEUR (361.3) and adjusted operating margin of 25.2% (26.6)Adjusted earnings per share including discontinued operations of 9.1 (9.4)Earnings per share including discontinued operations of 59.9 Euro cent (7.0)

For further information, please contact:
Tom Hull, Head of Investor Relations, +44 (0) 7442 678 437, ir@hexagon.com
Anton Heikenström, Investor Relations Manager, +46 8 601 26 26, ir@hexagon.com

This is information that Hexagon AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 08:00 CET on 23 April 2026.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/hexagon/r/hexagon-interim-report-1-january—31-march-2026,c4338783

The following files are available for download:

 

View original content:https://www.prnewswire.com/news-releases/hexagon-interim-report-1-january—31-march-2026-302751432.html

SOURCE Hexagon

Continue Reading

Technology

Dragonpass Empowers Financial Institutions with End-to-End Loyalty Solutions at Money20/20 Asia

Published

on

By

BANGKOK, April 23, 2026 /PRNewswire/ — Dragonpass, a leading global travel and lifestyle platform, participated in Money20/20 Asia, showcasing its customer loyalty solutions for banks, payment providers, credit card issuers, and fintech companies across APAC and globally.

As one of the most influential fintech events worldwide, Money20/20 Asia gathers decision-makers across the financial ecosystem. At the event, Dragonpass demonstrated how financial institutions can enhance customer engagement and build long-term loyalty through integrated travel and lifestyle experiences.

Established in 2005, Dragonpass has evolved from a lounge provider into a loyalty solutions partner, serving more than 800 global clients and over 40 million members worldwide.

At the core of Dragonpass is a business structure that combines global supply aggregation, a technology-enabled engagement platform, and consumer-facing lifestyle services — providing a one-stop solution across the customer lifecycle.

Leveraging data-driven insights, Dragonpass enables partners to design and optimise loyalty programs, incorporating customer segmentation and tiered incentive structures, alongside curated campaigns and entitlement configuration — driving more effective customer activation, engagement, and retention.

Its offering includes a broad portfolio of travel and lifestyle benefits such as airport lounge access, fast-track, dining, airport transfers, and lifestyle experiences. These are supported by flexible delivery models, including API integration, white-label solutions, and ready-to-deploy digital platforms, enabling seamless integration into clients’ customer journeys.

As customer expectations evolve, the industry is shifting from standardized benefits to more personalized, experience-led loyalty models. Insights from Dragonpass’s Loyalty Index show that customers increasingly value trust, rewards, simplicity, recognition, and exclusivity, with preferences varying across markets.

“Financial institutions today are looking for more effective ways to engage customers beyond traditional rewards,” said Jane Zhu, Co-founder and CEO of Dragonpass. “User engagement is at the core of loyalty, and technology — especially AI — plays a key role in enabling deeper and more relevant customer connections.”

Dragonpass works with leading global brands including Mastercard, Visa, HSBC, and Revolut, supporting them deliver differentiated value propositions and enhance customer engagement through scalable, customizable solutions.

Through its participation at Money20/20 Asia, Dragonpass aims to strengthen its presence in the APAC market and build strategic partnerships with organizations seeking to elevate their customer engagement strategies.

About Dragonpass

Dragonpass is a global travel and lifestyle platform providing premium airport and travel experiences across 140+ countries. By integrating global supply and technology, Dragonpass enables partners to deliver seamless, personalized experiences and drive customer loyalty.

Media Contact

Dragonpass PR
Email: brandmarketing@dragonpass.com
Website: www.dragonpass.com

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/dragonpass-empowers-financial-institutions-with-end-to-end-loyalty-solutions-at-money2020-asia-302751442.html

SOURCE Dragonpass

Continue Reading

Technology

SBI Life Insurance registers New Business Premium of ₹42,551 crores for the year ended on 31st March, 2026

Published

on

By

MUMBAI, India, April 23, 2026 /PRNewswire/ — SBI Life Insurance, one of the leading life insurers in the country registered a New Business Premium of ₹42,551 crores for the year ended on 31st March, 2026 vis-a-vis ₹35,577 crores for the year ended 31st March, 2025. Single premium has increased by 28% over the year ended on 31st March, 2025.

Establishing a clear focus on protection, SBI Life’s protection new business premium stood at ₹4,622 crores for the year ended 31st March, 2026, marking a growth of 13%. Protection Individual new business premium registered a growth of 23% and stood at ₹973 crores for the year ended 31st March, 2026. Individual New Business Premium stands at ₹29,783 crores with 13% growth over the year ended on 31st March, 2025.

SBI Life’s profit after tax stands at ₹2,470 crores for the year ended 31st March, 2026 with a growth of 2% over the year ended on 31st March, 2025.

The company’s solvency ratio continues to remain robust at 1.90 as on 31st March, 2026 as against the regulatory requirement of 1.50.

SBI Life’s AUM also continued to grow at 9% to ₹4,87,163 crores as on 31st March, 2026 from ₹4,48,039 crores as on 31st March, 2025, with the debt-equity mix of 62:38. 94% of the debt investments are in AAA and Sovereign instruments.

The company has a diversified distribution network of 3,58,506 trained insurance professionals and wide presence with 1,230 offices across the country, comprising of strong bancassurance channel, agency channel and others comprising of corporate agents, brokers, Point of Sale Persons (POS), insurance marketing firms, web aggregators and direct business.

Performance for the year ended March 31, 2026

Private Market leadership in Individual New Business Premium and Individual Rated Premium with market share of 25.5% & 22.9% respectively.Annualized Premium Equivalent (APE) stands at ₹ 24,266 crores with growth of 13%Individual New Business Sum Assured stands at ₹ 4,46,337 crores with 61% growthImprovement in 13M & 49M persistency by 53 bps & 107 bps respectivelyValue of New Business (VoNB) stands at ₹ 6,667 crores with growth of 12%VoNB Margin stands at 27.5%Indian Embedded value (IEV) stands at ₹ 80,791 crores with 15% growthProfit After Tax (PAT) stands at ₹ 2,470 crores with 2% growthOperating Return on Embedded Value stands at 19.7% Assets under Management stands at ₹ 4,87,163 crores with 9% growthRobust Solvency ratio of 1.90

Logo: https://mma.prnewswire.com/media/2672544/SBI_Life_25_Years_Logo.jpg

 

View original content:https://www.prnewswire.com/in/news-releases/sbi-life-insurance-registers-new-business-premium-of-42-551-crores-for-the-year-ended-on-31st-march-2026–302751447.html

Continue Reading

Trending